Pharmaceutical Executive
Outlining three practices that are key to navigating today’s multiplayer agency landscape - and getting more value from each external vendor.
Justin Grossman
Advertisement
Justin Grossman is Managing Partner, multimedia.
Articles by Justin Grossman
Clinical trials for precision therapies will require a healthy dose of education, collaboration, and data-driven decision-making from everyone involved in the process―not to mention a dedication to digital technology. Justin Grossman reports.
Creating a culture of analytics will help you get the most out of your marketing efforts, writes Justin Grossman.
Advertisement
Latest Updated Articles
- How to Get Your Marketing Team to Drive with Data
March 8th 2019
How Precision Medicine Will Revolutionize Trial RecruitmentMarch 20th 2019
Three Tips to Managing Multiple Agency PartnersAugust 1st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5